These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. POST-HEPARIN LIPOLYTIC ACTIVITY FOLLOWING INTRAVENOUS HEPARIN-S35. PORTE D; WILLIAMS RH Proc Soc Exp Biol Med; 1965 Mar; 118():639-43. PubMed ID: 14264516 [No Abstract] [Full Text] [Related]
23. THE EFFECT OF HEPARIN PRETREATMENT ON DEVELOPMENT AND CLEARING OF ALIMENTARY LIPEMIA. Barboriak JJ; Kory RC; Chamilton LH Am J Clin Nutr; 1965 May; 16():412-6. PubMed ID: 14286798 [No Abstract] [Full Text] [Related]
24. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES. SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H Neurology; 1965 May; 15():486-90. PubMed ID: 14288641 [No Abstract] [Full Text] [Related]
25. Lipoprotein lipase in rat lung. The effect of fasting. Hamosh M; Hamosh P Biochim Biophys Acta; 1975 Jan; 380(1):132-40. PubMed ID: 235320 [TBL] [Abstract][Full Text] [Related]
26. [METHODS OF EVALUATING ANTILIPEMIC ACTION IN VIVO AND IN VITRO IN RATS]. HORNACEK J; HLADOVEC J; KRPATOVA J Cas Lek Cesk; 1963 May; 102():641-4. PubMed ID: 14077274 [No Abstract] [Full Text] [Related]
27. [ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION]. SCHOELL H; KOPITZKI F Klin Wochenschr; 1964 Jul; 42():699-707. PubMed ID: 14250912 [No Abstract] [Full Text] [Related]
28. [INFLUENCE OF ORAL LIPID ADMINISTRATION ON THE POST-HEPARIN "CLEARING" AND "LIPOLYTIC" POWER IN HEALTHY YOUNG PERSONS AND IN AGED ARTERIOSCLEROTIC PATIENTS]. CONCONI F; MANENTI F; TORRI A; NAVA C Acta Vitaminol; 1964 Feb; 18():13-21. PubMed ID: 14157826 [No Abstract] [Full Text] [Related]
29. [Alimentary lipemia and post-heparin lipoprotein lipase activity (PHLA) in children with dysthyroidism]. Szczepski O; Walczak M; Korman E; Rakowska E; Rakowski W; Socha J Endokrynol Pol; 1974; 25(3):205-10. PubMed ID: 4844987 [No Abstract] [Full Text] [Related]
30. STUDIES OF THE INFLUENCE OF DIET ON CLEARING-FACTOR LIPASE (CFL) AND BLOOD LIPID LEVELS OF A PATIENT WITH HYPERLIPIDEMIA. MACNAB M; MACMILLAN RL; MONKHOUSE FC Can Med Assoc J; 1965 Jan; 92(5):217-20. PubMed ID: 14246294 [TBL] [Abstract][Full Text] [Related]
31. [On the effects of prostaglandin El and insulin on the heparin-induced triglyceride hydrolysis]. Böhle E; Döbert R; Merkl IM Z Gesamte Exp Med Einschl Exp Chir; 1967 Sep; 144(4):285-99. PubMed ID: 5589354 [No Abstract] [Full Text] [Related]
32. Cortisone nephropathy in the rabbit. The effect of heparin on the morphology, plasma lipid levels and plasma lipoprotein lipase activity. Rammer L; Nathorst-Windahl G; Boberg J Acta Pathol Microbiol Scand; 1967; 71(2):161-72. PubMed ID: 5582842 [No Abstract] [Full Text] [Related]
33. [Lipoprotein lipase activity following heparin infusion. II. Patients with healed myocardial infarct]. Giannini SD; Diament J; Silva Pde P Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(2):91-8. PubMed ID: 5520720 [No Abstract] [Full Text] [Related]
34. LIPOLYTIC ACTIVITY AND PLASMA-FREE FATTY ACID LEVELS FOLLOWING THE ADMINISTRATON OF AN INHIBITOR OF THE CLEARING REACTION. HOLLETT CR Biochim Biophys Acta; 1965 Feb; 98():61-5. PubMed ID: 14290839 [No Abstract] [Full Text] [Related]
35. Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. Lespine A; Chap H; Perret B Biochim Biophys Acta; 1997 Mar; 1345(1):77-85. PubMed ID: 9084504 [TBL] [Abstract][Full Text] [Related]